Advanced Quantitative Analytics Platform
Loading...
⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, signals and grades are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.|Contact: [email protected]
Sector: Healthcare · Market cap: 1.3 mld. $ · Price: $94.81 · Data as of 2026-06-29
Kompozitní skóre 56/100 staví Inhibrx Biosciences, Inc. do neutrálního pásma, čímž překonává 89 % z 19 907 sledovaných akcií. Nejvýraznější vrstvou je Kvalita zisků, naopak nejslabší je Fundamentální hodnota.
The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.
| Layer | Score |
|---|---|
| Fundamentální hodnota (FVS) | 12/100 |
| Kvalita zisků (EQS) | 95/100 |
| Technický trend (TSS) | 54/100 |
| Relativní síla (RS) | 65/100 |
| Momentum (USS) | 58/100 |
| Insider aktivita (IAS) | 63/100 |
| Dark pool / velrybí toky (WHS) | 66/100 |
| Institucionální 13F (IFS) | 65/100 |
| Analytici / transkripty (ATS) | 82/100 |
| Katalyzátory (XS) | 53/100 |
The composite score is an entry point, not a signal. What matters is layer confluence — whether they point the same direction.
U INBX se vrstvy rozcházejí — některé signály jsou silné (Kvalita zisků), jiné slabé (Fundamentální hodnota). Rozpor mezi vrstvami je sám o sobě informací: model nedává jednoznačný obrázek. Skóre je vstup do vašeho rozhodování, ne doporučení.
Za poslední období evidujeme u INBX více insiderských nákupů (5) než prodejů (0). Model to hodnotí jako „STRONG_BUY". 5 insiderů nakoupilo za $12.2M, 0 prodejů za 180 dní — silná akumulace. CEO nakupuje. 2 potvrzení.
INBX is currently in its seasonal window 1. červen–28. červen with a hit rate of 67% and an average move of 2.9% (7 years of history).
Historical data does not guarantee future results.
Inhibrx Biosciences, Inc. currently carries a dividend yield of 0.90% and has paid for 1 years in a row.
Similar stocks from the same sector:
What is the composite score for INBX stock?
56.3/100 (grade B) as of 2026-06-29, fusing 10 data layers. An analytical score, not advice.
Are insiders buying INBX stock?
Over the recent period: 5 buys and 0 sells. Assessment: STRONG_BUY.
Where can I see live INBX data?
Live INBX data and all 17,000+ stocks unlock with QMA trial access from $4.90.
Want the full INBX analysis with all layers and live data? Open INBX detail →
Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.